Patents by Inventor Marvin L. Lewbart

Marvin L. Lewbart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STEROID TETROL SOLID STATE FORMS
    Publication number: 20090143349
    Abstract: The invention relates to solid state forms of androst-5-ene-3?,7?,16?,17?-triol, formulations containing or prepared from such solid state forms and use of such materials for modulating acute and chronic non-productive inflammation. The formulations can be used to prevent, treat or slow the progression of conditions related to autoimmunity such as arthritis, multiple sclerosis, ulcerative colitis or Type 1 diabetes. The formulations can also be used to prevent, treat or slow the progression of conditions related to metabolic disorders such as Type 2 diabetes.
    Type: Application
    Filed: November 17, 2008
    Publication date: June 4, 2009
    Inventors: Marvin L. Lewbart, James M. Frincke, Christopher L. Reading
  • 7-Hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof
    Publication number: 20040034003
    Abstract: The present invention relates to 7-hydroxy-16&agr;-fluoro-5-androsten-17-one and 7-hydroxy-16&agr;-fluoro-5-androstan-17-one derivatives and their use.
    Type: Application
    Filed: May 1, 2003
    Publication date: February 19, 2004
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • 5 .alpha.-pregnan-20-ones and 5-pregnen-20-ones and related compounds
    Patent number: 5175154
    Abstract: Compounds of the formulae: ##STR1## useful as anti-obesity, anti-diabetic, anti-coronary and hypolipidemic agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: December 29, 1992
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Method for prophylaxis of obesity
    Patent number: 5157031
    Type: Grant
    Filed: March 21, 1989
    Date of Patent: October 20, 1992
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Homoandrostan-17-one and homoandrosten-17-ones
    Patent number: 5028631
    Abstract: Compounds of the formula: ##STR1## useful as anti-cancer agents, anti-obesity agents, anti-hyperglycemic agents, anti-aging agents, anti-hyperglycemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: July 2, 1991
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • 16-substituted androstanes and 16-substituted androstenes
    Patent number: 5001119
    Abstract: Compounds of the formula: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: March 19, 1991
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • 17-Hydroxy-steroids
    Patent number: 4898694
    Abstract: Compounds of the formulae: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: February 6, 1990
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Prednisolone derivatives
    Patent number: 4511511
    Abstract: Novel prednisolone derivatives modified at C-17,C-20 and/or C-21 positions. Many of the compounds are anti-inflammatory agents which do not significantly suppress the pituitary-adrenal axis.
    Type: Grant
    Filed: December 15, 1982
    Date of Patent: April 16, 1985
    Assignee: Crozer-Chester Medical Center
    Inventor: Marvin L. Lewbart